Jürgen Raths
Corporate Officer/Principal bei Executive Insight AG
Aktive Positionen von Jürgen Raths
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Executive Insight AG | Corporate Officer/Principal | 01.01.2015 | - |
Karriereverlauf von Jürgen Raths
Ehemalige bekannte Positionen von Jürgen Raths
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PAION AG | Geschäftsführer | 31.08.2015 | 01.03.2017 |
Advanz Pharma Switzerland SARL
 Advanz Pharma Switzerland SARL Pharmaceuticals: MajorHealth Technology Advanz Pharma Switzerland SARL manufactures and wholesales pharmaceuticals. The company is headquartered in Geneva, Switzerland. | Vorstandsvorsitzender | 01.01.2010 | 01.01.2013 |
| Präsident | 01.01.2010 | 01.01.2013 | |
Arpida AG
 Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Präsident | 01.05.2008 | 14.12.2009 |
| Eli Lilly (Suisse) SA | Corporate Officer/Principal | 01.01.1990 | 01.01.2008 |
Vesselon, Inc.
 Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Jürgen Raths
| University of Bonn | Doctorate Degree |
Statistik
International
| Schweiz | 5 |
| Deutschland | 3 |
| Vereinigte Staaten | 2 |
Operativ
| President | 2 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PAION AG | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Arpida AG
Arpida AG BiotechnologyHealth Technology Arpida AG develops and discovers drugs for microbial resistance. The company's products include intravenous iclaprim, and antibiotics. The antibiotics provides resistance towards the methicillin-resistant Staphylococcus aureus (MRSA). The company also discovers an oral formulation of iclaprim. The company was founded by Dr. Dieter Gillessen, Bernhard Erni and Dr. Ivan Kompis in July 1997 and is headquartered in Reinach, Switzerland. | Health Technology |
Advanz Pharma Switzerland SARL
Advanz Pharma Switzerland SARL Pharmaceuticals: MajorHealth Technology Advanz Pharma Switzerland SARL manufactures and wholesales pharmaceuticals. The company is headquartered in Geneva, Switzerland. | Health Technology |
| Eli Lilly (Suisse) SA | |
| Executive Insight AG | |
Vesselon, Inc.
Vesselon, Inc. Medical SpecialtiesHealth Technology Vesselon, Inc. develops a portable ultrasound medical device for treating neurodegenerative diseases and brain & ischemic strokes. It commercializes a drug delivery platform that combines ultrasound and microbubbles to deliver the drugs across tissue barriers directly into a target without the need to modify the drug through a process, microbubble assisted sono-therapy. The company was founded by Clayton T. Larsen and Rhodemann Li in 2012 and is headquartered in Norwalk, CT. | Health Technology |
- Börse
- Insiders
- Jürgen Raths
- Erfahrung
